Literature DB >> 29343432

HIV Immunogens: Affinity Is Key.

Savit Prabhu1, Ian A Cockburn1, Carola G Vinuesa2.   

Abstract

Generation of broadly neutralizing antibodies is a key aim of HIV vaccine design, but the precursor B cells are rare. Abbott et al. (2018) report that high affinity and avidity immunogens are required to promote maturation of low frequency B cells in germinal centers.
Copyright © 2018. Published by Elsevier Inc.

Mesh:

Substances:

Year:  2018        PMID: 29343432     DOI: 10.1016/j.immuni.2018.01.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  1 in total

Review 1.  Innovations in HIV-1 Vaccine Design.

Authors:  Letitia D Jones; M Anthony Moody; Amelia B Thompson
Journal:  Clin Ther       Date:  2020-02-05       Impact factor: 3.393

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.